BIPH:OTO-Biophan Techs Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC Pink

Last Closing

USD 17.8548

Change

+0.36 (+2.09)%

Market Cap

USD 0.19M

Volume

0.01M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Biophan Technologies Inc develops and markets cutting-edge technologies for the medical device industry. It develops biomedical devices that improve the delivery of healthcare.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+2.77 (+1.20%)

USD 68.18B
ALC Alcon AG

-0.63 (-0.70%)

USD 44.25B
HYB New America High Income Closed..

+0.05 (+0.69%)

USD 35.93B
RMD ResMed Inc

-0.16 (-0.08%)

USD 30.24B
WST West Pharmaceutical Services I..

+0.63 (+0.19%)

USD 24.60B
BAX Baxter International Inc

-0.07 (-0.21%)

USD 17.42B
ATR AptarGroup Inc

-3.06 (-2.13%)

USD 9.72B
TFX Teleflex Incorporated

+3.10 (+1.50%)

USD 9.36B
XRAY Dentsply Sirona Inc

-0.38 (-1.50%)

USD 5.33B
BLCO Bausch + Lomb Corp

-0.25 (-1.69%)

USD 5.25B

ETFs Containing BIPH

ABEQ Absolute Core Strategy ET.. 6.53 % 0.00 %

-0.13 (0.64%)

USD 0.09B
C40:SW Amundi Index Solutions - .. 5.31 % 0.00 %

N/A

USD 0.90B
C4DE:SW Amundi Index Solutions - .. 5.31 % 0.00 %

N/A

USD 0.15B
ASWC:XETRA HANetf ICAV - Future of D.. 5.15 % 0.00 %

+0.06 (+0.64%)

USD 0.39B
XEYX:XETRA BNP Paribas Easy CAC 40®.. 5.08 % 0.00 %

-0.10 (0.64%)

USD 0.32B
DEMZ Democratic Large Cap Core.. 4.84 % 0.00 %

-0.13 (0.64%)

USD 0.04B
SPYQ:F SSgA SPDR ETFs Europe II .. 4.25 % 0.00 %

-2.10 (0.64%)

USD 0.34B
IS3U:F iShares IV Public Limited.. 3.90 % 0.00 %

-0.88 (0.64%)

USD 0.12B
CGGO Capital Group Global Grow.. 2.94 % 0.00 %

-0.26 (0.64%)

USD 3.77B
LGWT:F Lyxor Index Fund - Lyxor .. 2.70 % 0.00 %

-0.82 (0.64%)

USD 0.20B
IEMO:SW iShares Edge MSCI Europe .. 2.53 % 0.00 %

N/A

USD 0.34B
VVGM:XETRA VanEck Morningstar Global.. 2.28 % 0.00 %

+0.03 (+0.64%)

USD 0.07B
SPVM Invesco S&P 500 Value wit.. 1.44 % 0.39 %

+0.28 (+0.64%)

USD 0.09B
LOWV:LSE SPDR® S&P 500 Low Volati.. 1.16 % 0.00 %

-0.05 (0.64%)

USD 0.13B
USLV:LSE SPDR® S&P 500 Low Volati.. 1.16 % 0.00 %

-0.05 (0.64%)

USD 0.12B
AVSD American Century ETF Trus.. 0.59 % 0.00 %

-0.05 (0.64%)

USD 0.14B
CFO VictoryShares US 500 Enha.. 0.36 % 0.35 %

-0.09 (0.64%)

USD 0.43B
CFA VictoryShares US 500 Vola.. 0.35 % 0.35 %

N/A

USD 0.51B
EWQ iShares MSCI France ETF 0.00 % 0.47 %

-0.19 (0.64%)

USD 0.60B
BDIV:CA Brompton Global Dividend .. 0.00 % 0.96 %

+0.06 (+0.64%)

CAD 0.09B
EDGF:CA Brompton European Dividen.. 0.00 % 0.00 %

N/A

CAD 0.02B
CACX:LSE Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

-46.50 (0.64%)

USD 3.39B
DXG:CA Dynamic Active Global Div.. 0.00 % 0.82 %

-0.40 (0.64%)

CAD 0.68B
IDJG:LSE iShares EURO Total Market.. 0.00 % 0.00 %

-10.50 (0.64%)

USD 0.33B
IEFM:LSE iShares Edge MSCI Europe .. 0.00 % 0.00 %

+1.00 (+0.64%)

USD 0.33B
IEMD:LSE iShares Edge MSCI Europe .. 0.00 % 0.00 %

N/A

USD 7.47M
ISFR:LSE iShares MSCI France UCITS 0.00 % 0.00 %

-30.25 (0.64%)

USD 0.11B
NDUS:LSE SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

-1.55 (0.64%)

USD 0.35B
CEMR:F iShares Edge MSCI Europe .. 0.00 % 0.00 %

-0.01 (0.64%)

USD 0.33B
EXH4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

-0.25 (0.64%)

USD 0.20B
GC40:F Amundi Index Solutions - .. 0.00 % 0.00 %

-1.32 (0.64%)

USD 0.91B
IQQG:F iShares Public Limited Co.. 0.00 % 0.00 %

-0.37 (0.64%)

USD 0.31B
JIG JPMorgan International Gr.. 0.00 % 0.00 %

+0.04 (+0.64%)

USD 0.09B
FCSI:CA Franklin ClearBridge Sust.. 0.00 % 0.00 %

+0.01 (+0.64%)

CAD 4.28M
ESIN:LSE iShares MSCI Europe Indus.. 0.00 % 0.00 %

-0.01 (0.64%)

USD 0.20B
ESIN:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

-0.05 (0.64%)

USD 0.21B
ESIN:XETRA Ishares VI PLC - Ishares .. 0.00 % 0.00 %

-0.02 (0.64%)

USD 0.16B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.41% 79% B- 67% D+
Dividend Return 3.72% 100% F 84% B
Total Return 10.13% 84% B 73% C
Trailing 12 Months  
Capital Gain 1.33% 74% C 39% F
Dividend Return 3.55% 89% A- 52% F
Total Return 4.88% 74% C 38% F
Trailing 5 Years  
Capital Gain N/A 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 73,601.24% 100% F 100% F
Dividend Return 73,603.48% 100% F 100% F
Total Return 2.24% 90% A- 50% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 5% F N/A F
Risk Adjusted Return 31.72% 68% D+ 54% F
Market Capitalization 0.19M 5% F N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.